Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Faricimab or Fluocinolone Acetonide vs Observation for Radiation Retinopathy
NCT05844982Phase 3Recruiting
- Sponsor
- Jaeb Center for Health Research
- Start
- Nov 2023
- Primary completion
- Dec 2029
- Modality
- Bispecific Antibodies, Orthosteric Ligands, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 3 trial of faricimab, fluocinolone in radiation retinopathy (RR), sponsored by Jaeb Center for Health Research. Started Nov 2023; status: recruiting.
02
Drugs
faricimabfluocinolone
03
Conditions
radiation retinopathy (RR)
Beyond the preview
Go deeper on NCT05844982.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05844982.